CDKN1B and colorectal carcinoma: MiR-452: MiR-452 activates Wnt/β-catenin through GSK3β suppression and might evoke cell cycle progression in CRC by blocking cyclin-dependent kinase inhibitor 1B (CDKN1B) [205].